Relative Risk of Adverse Events and Treatment Discontinuations Between Older and Non-Older Adults Treated with Antimuscarinics for Overactive Bladder: A Systematic Review and Meta-Analysis.
Silken A UsmaniKristine ReckenbergOlivia JohnsonPaul M StrangesBesu F TeshomeClark D KebodeauxScott Martin VouriPublished in: Drugs & aging (2019)
Treatment of OAB with antimuscarinics in the older population resulted in significantly higher rates of AEs, barring headache, when compared with non-older subjects.